Dexamethasone Intravitreal Implant for the Treatment of Macular Edema Following Retinal Vein Occlusion: Post Hoc Analysis of Post-Marketing Surveillance Data in the Real-World Setting in Korea

References

• Rehak M, Wiedemann P. Retinal vein thrombosis: pathogenesis and management. J Thromb Haemost. 2010;8:1886–1894. doi:10.1111/j.1538-7836.2010.03909.x
   PubMed Web of Science ®Google Scholar
• Central Vein Occlusion Study Group. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol. 1993;111:1087–1095. doi:10.1001/archopht.1993.01090080083022
   PubMedGoogle Scholar
• Finkelstein D. Argon laser photocoagulation for macular edema in branch vein occlusion. Ophthalmology. 1986;93:975. doi:10.1016/S0161-6420(86)33651-0
   Web of Science ®Google Scholar
• The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion. Am J Ophthalmol. 1984;98:271–282. doi:10.1016/0002-9394(84)90316-7
   PubMed Web of Science ®Google Scholar
• Adelman R, Parnes A, Bopp S, Saad Othman I, Ducournau D; EVRS Macular Edema Study Group. Strategy for the management of macular edema in retinal vein occlusion: the European VitreoRetinal Society macular edema study. Biomed Res Int. 2015;870987.
   Google Scholar
• Haller J, Bandello F, Belfort R, et al. Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion. Ophthalmology. 2010;117:1134–1146. doi:10.1016/j.ophtha.2010.03.032
   PubMed Web of Science ®Google Scholar
• Haller J, Bandello F, Belfort R, et al. Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results. Ophthalmology. 2011;118:2453–2460. doi:10.1016/j.ophtha.2011.05.014
   PubMed Web of Science ®Google Scholar
• Li X, Wang N, Liang X, et al. Safety and efficacy of dexamethasone intravitreal implant for treatment of macular edema secondary to retinal vein occlusion in Chinese patients: randomized, sham-controlled, multicenter study. Graefes Arch Clin Exp Ophthalmol. 2018;256:59–69. doi:10.1007/s00417-017-3831-6
   Web of Science ®Google Scholar
• Kim HS, Lee S, Kim JH. Real-world evidence versus randomized controlled trial: clinical research based on electronic medical records. J Korean Med Sci. 2018;33:e213. doi:10.3346/jkms.2018.33.e213
   PubMed Web of Science ®Google Scholar
• Kim HS, Kim H, Jeong YJ, et al. Comparative analysis of the suspected heparin-induced thrombocytopenia level in Korea. Basic Clin Pharmacol Toxicol. 2017;121:360–367. doi:10.1111/bcpt.12791
   Web of Science ®Google Scholar
• Lam WC, Albiani DA, Yoganathan P, et al. Real-world assessment of intravitreal dexamethasone implant (0.7 mg) in patients with macular edema: the CHROME study. Clin Ophthalmol. 2015;9:1255–1268. doi:10.2147/OPTH.S80500
   PubMed Web of Science ®Google Scholar
• Eter N, Mohr A, Wachtlin J, et al. Dexamethasone intravitreal implant in retinal vein occlusion: real-life data from a prospective, multicenter clinical trial. Graefes Arch Clin Exp Ophthalmol. 2017;255:77–87. doi:10.1007/s00417-016-3431-x
   PubMed Web of Science ®Google Scholar
• Tufail A, Lightman S, Kamal A, et al. Post-marketing surveillance study of the safety of dexamethasone intravitreal implant in patients with retinal vein occlusion or noninfectious posterior segment uveitis. Clin Ophthalmol. 2018;12:2519–2534. doi:10.2147/OPTH.S181256
   PubMed Web of Science ®Google Scholar
• Querques L, Querques G, Lattanzio R, et al. Repeated intravitreal dexamethasone implant (Ozurdex®) for retinal vein occlusion. Ophthalmologica. 2013;229:21–25. doi:10.1159/000342160
   PubMed Web of Science ®Google Scholar
• Coscas G, Augustin A, Bandello F, et al. Retreatment with Ozurdex for macular edema secondary to retinal vein occlusion. Eur J Ophthalmol. 2014;24:1–9. doi:10.5301/ejo.5000376
   PubMed Web of Science ®Google Scholar
• Fortoul V, Denis P, Kodjikian L. Anatomical and functional recurrence after dexamethasone intravitreal implants: a 6-month prospective study. Eye (Lond). 2015;29:769–775. doi:10.1038/eye.2015.36
   Web of Science ®Google Scholar
• Capone A, Singer MA, Dodwell DG, et al. Efficacy and safety of two or more dexamethasone intravitreal implant injections for treatment of macular edema related to retinal vein occlusion (SHASTA study). Retina. 2014;34:342–351. doi:10.1097/IAE.0b013e318297f842
   Web of Science ®Google Scholar
• Callizo J, Ziemssen F, Bertelmann T, et al. Real-world data: ranibizumab treatment for retinal vein occlusion in the OCEAN study. Clin Ophthalmol. 2019;13:2167–2179. doi:10.2147/OPTH.S209253
   PubMed Web of Science ®Google Scholar
• Chatziralli I, Theodossiadis G, Moschos MM, Mitropoulos P, Theodossiadis P. Ranibizumab versus aflibercept for macular edema due to central retinal vein occlusion: 18-month results in real-life data. Graefes Arch Clin Exp Ophthalmol. 2017;255:1093–1100. doi:10.1007/s00417-017-3613-1
   Web of Science ®Google Scholar
• Vaz-Pereira S, Marques IP, Matias J, Mira F, Ribeiro L, Flores R. Real-world outcomes of anti-VEGF treatment for retinal vein occlusion in Portugal. Eur J Ophthalmol. 2017;27:756–761. doi:10.5301/ejo.5000943
   Web of Science ®Google Scholar
• Yoon Y, Kim J, Lee J, et al. Dexamethasone intravitreal implant for early treatment and retreatment of macular edema related to branch retinal vein occlusion: the multicenter COBALT study. Ophthalmologica. 2018;240:81–89. doi:10.1159/000487547
   Web of Science ®Google Scholar
• Bezatis A, Spital G, Höhn F, et al. Functional and anatomical results after a single intravitreal injection in retinal vein occlusion: a 6-month follow-up - the SOLO study. Acta Ophthalmol. 2013;91:e340–e347. doi:10.1111/aos.12020
   PubMed Web of Science ®Google Scholar
• Kanra AY, Akçakaya AA, Yaylalı SA, Altınel MG, Sevimli N. The efficacy and safety of intravitreal dexamethasone implant for the treatment of macular edema related to retinal vein occlusion: real-life data and prognostic factors in a Turkish population. Turk J Ophthalmol. 2017;47:331–337. doi:10.4274/tjo.75317
   Google Scholar
• Kim SJ, Yoon YH, Kim HK, et al. Baseline predictors of visual acuity and retinal thickness in patients with retinal vein occlusion. J Korean Med Sci. 2015;30:475–482. doi:10.3346/jkms.2015.30.4.475
   Web of Science ®Google Scholar
• Reid GA, Sahota DS, Sarhan M. Observed complications from dexamethasone intravitreal implant for the treatment of macular edema in retinal vein occlusion over 3 treatment rounds. Retina. 2015;35:1647–1655. doi:10.1097/IAE.0000000000000524
   PubMed Web of Science ®Google Scholar
• Jonas J, Paques M, Mones J, Glacet-Bernard A. Retinal vein occlusions. Dev Ophthalmol. 2010;47:111–135.
   PubMedGoogle Scholar